Skip to main content

Want a detailed portfolio tracker?

Aptorum Group (APM) P/E (2018 - 2026)

Aptorum Group (APM) P/E from Dec 31, 2018 to Jun 3, 2026. The TTM Aptorum Group (APM) P/E is -5.89. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Aptorum Group (APM)

YearP/EChange
2026-5.89+2.83%
2025-5.73+60.25%
2024-3.58+371.72%
2023-0.76-1.47%
2022-0.77-63.33%
2021-2.10-113.42%
202015.63-163.54%
2019-24.60-13.89%
2018-28.57N/A

Comparison Aptorum Group (APM) P/E with competitors

Aptorum Group (APM) P/E is -5.89.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.10-101.73%
ENLVEnlivex Therapeutics Ltd0.15-102.55%
FGENFibroGen Inc0.24-104.07%
TRAWTraws Pharma Inc0.47-108.02%
FBIOFortress Biotech Inc0.71-111.98%
CHRSCoherus Biosciences Inc0.98-116.60%
ORMPOramed Pharmaceuticals Inc1.47-125.01%
AGENAgenus Inc2.05-134.76%
VIVSVivoSim Labs Inc2.54-143.03%
INVAInnoviva Inc3.19-154.11%
CRMDCorMedix Inc3.65-161.87%
ABEOAbeona Therapeutics Inc4.20-171.36%
VXRTVaxart Inc4.26-172.32%
CVACCureVac N.V.4.45-175.45%
SRPTSarepta Therapeutics Inc4.62-178.48%
GLPGGalapagos NV4.86-182.46%
RIGLRigel Pharmaceuticals4.92-183.49%
ZVRAZevra Therapeutics Inc4.97-184.41%
ABUSArbutus Biopharma Corp5.69-196.63%
CGENCompugen Ltd7.38-225.31%
AUPHAurinia Pharmaceuticals Inc9.25-257.01%
ACADAcadia Pharmaceuticals Inc9.59-262.72%
OMEROmeros Corporation9.88-267.73%
PLXProtalix BioTherapeutics Inc9.91-268.17%
SPROSpero Therapeutics Inc10.73-282.18%
ADMAAdma Biologics Inc11.33-292.30%
SVASinovac Biotech Ltd11.44-294.08%
TBPHTheravance Biopharma Inc11.78-299.86%
HRMYHarmony Biosciences Holdings Inc12.18-306.72%
TGTXTG Therapeutics Inc13.18-323.67%
INCYIncyte Corp13.38-327.11%
SABSSAB Biotherapeutics Inc14.06-338.58%
XOMAXOMA Corp14.95-353.64%
REGNRegeneron Pharmaceuticals Inc14.98-354.23%
PBYIPuma Biotechnology Inc15.05-355.43%
EXELExelixis Inc15.79-368.06%
NAGENiagen Bioscience Inc16.35-377.57%
CPRXCatalyst Pharmaceuticals Inc17.34-394.36%
MDXGMimedx Group Inc17.38-394.88%
ARGXArgen X SE23.07-491.56%
HALOHalozyme Therapeutics Inc23.20-493.75%
XOMAOXOMA Corp25.34-530.14%
VRTXVertex Pharmaceuticals Inc25.66-535.41%
XOMAPXOMA Corp25.67-535.66%
CTMXCytomX Therapeutics Inc25.70-536.13%
ASNDAscendis Pharma A/S26.35-547.26%
RPRXRoyalty Pharma plc - Class A27.50-566.63%
SLNOSoleno Therapeutics Inc29.02-592.43%
LGNDLigand Pharmaceuticals Inc - Class B30.19-612.31%
BMRNBiomarin Pharmaceutical Inc37.51-736.55%
KRYSKrystal Biotech Inc39.70-773.72%
GMABGenmab40.20-782.31%
ONCBeiGene Ltd67.03-1237.54%
TECHBio-Techne Corp68.59-1264.15%
VCELVericel Corp80.63-1468.39%
PHARPharming Group N.V.87.74-1589.07%
ALNYAlnylam Pharmaceuticals Inc124.93-2220.30%
TLXTelix Pharmaceuticals Ltd139.89-2474.14%
CORTCorcept Therapeutics Inc158.39-2788.08%